You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

immune therapy pre-treated

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer Trial in Louisville (4D-CT pre-treatment scan)

Active, not recruiting
  • Lung Cancer
  • 4D-CT pre-treatment scan
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Jun 21, 2021

Rectal Cancer Trial in United States (Short Course Radiation Therapy (scRT), Total Mesenteric Excision (TME))

Recruiting
  • Rectal Cancer
  • Short Course Radiation Therapy (scRT)
  • Total Mesenteric Excision (TME)
  • Los Angeles, California
  • +5 more
Jul 3, 2023

Blocking TNF to Potentiate ICI-dependent Immune Awakening in

Recruiting
  • Melanoma
  • +2 more
    • Toulouse, France
      Institut Claudius Regaud
    May 25, 2023

    Female Breast Cancer Trial in Germany

    Recruiting
    • Female Breast Cancer
      • Moenchengladbach, NRW, Germany
      • +4 more
      Mar 30, 2023

      Stage II Nasopharyngeal Carcinoma AJCC v8, Stage III Nasopharyngeal Carcinoma AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8

      Not yet recruiting
      • Stage II Nasopharyngeal Carcinoma AJCC v8
      • +2 more
      • Biopsy
      • +16 more
      • (no location specified)
      Oct 7, 2023

      Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant, Avelumab)

      Active, not recruiting
      • Metastatic Breast Cancer
      • Miami, Florida
      • +21 more
      Mar 18, 2022

      Immune Profiling for Cancer Immunotherapy Response

      Recruiting
      • Cancer
      • +3 more
      • Methylation Cytometry
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Medical Center
      Nov 6, 2023

      Basal Cell Carcinoma Trial in Cleveland (ALA, PDT)

      Recruiting
      • Basal Cell Carcinoma
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      Mar 2, 2022

      Liver Toxicity in Lung Cancer Patients Treated With

      Recruiting
      • Lung Cancer Stage IV
      • +2 more
      • No intervention due to observational methods of study
      • Sydney, New South Wales, Australia
      • +2 more
      Jan 19, 2022

      Osteosarcoma Trial in Shanghai (metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic

      Recruiting
      • Osteosarcoma
      • metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic body radiotherapy
      • Shanghai, Shanghai, China
        Ruijin Hospital, Shanghai Jiao Tong University, School of Medici
      Nov 1, 2023

      Melanoma Trial in France (Nivolumab + Ipilimumab, Combined treatment schema)

      Terminated
      • Melanoma
      • Nivolumab + Ipilimumab
      • Combined treatment schema
      • Bordeaux, France
      • +5 more
      Dec 3, 2020

      Immunophenotyping in Metastatic Kidney Cancer Patients Receiving

      Recruiting
      • Metastatic Renal Cell Carcinoma
      • Stage IV Renal Cell Cancer AJCC v8
      • Biospecimen Collection
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 6, 2023

      Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)

      Recruiting
      • Squamous Cell Cancers of the Head and Neck
      • New Haven, Connecticut
        Yale Cancer Center
      Jan 10, 2023

      Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)

      Completed
      • Cancer, Treatment-Related
      • +3 more
      • cryoablation
      • Roma, Italy
        Sapienza University of Rome
      Feb 13, 2023

      Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

      Not yet recruiting
      • Primary Immune Thrombocytopenia (ITP)
      • Ianalumab
      • (no location specified)
      Jun 5, 2023

      Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)

      Recruiting
      • Non-Hodgkin Lymphoma
      • Biospecimen Collection
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jan 13, 2023

      Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

      Active, not recruiting
      • Adult Acute Lymphoblastic Leukemia in Remission
      • +14 more
      • radiation therapy
      • +8 more
      • Columbus, Ohio
        Arthur G. James Cancer Hospital and Solove Research Institute at
      Oct 7, 2022

      Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

      Not yet recruiting
      • Carcinoma, Renal Cell
      • Pittsburgh, Pennsylvania
        UPMC Department of Urology
      Jan 5, 2023

      Metastatic Malignant Solid Tumor Trial in Duarte (procedure, radiation, drug)

      Recruiting
      • Metastatic Malignant Solid Neoplasm
      • Lymphoma
      • Positron Emission Tomography
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      Nov 18, 2022

      Advanced Liver Cancers Trial (DC-CIK)

      Not yet recruiting
      • Advanced Liver Cancers
      • DC-CIK
      • (no location specified)
      Nov 11, 2022

      Endocrine Autoimmune Toxicity Due to Immune Checkpoint

      Recruiting
      • Thyroid
      • +2 more
        • New York, New York
          Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment C
        Oct 25, 2022

        Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

        Recruiting
        • Metastatic Malignant Neoplasm in the Liver
        • Neuroendocrine Neoplasm
        • Arterial Embolization
        • +3 more
        • San Francisco, California
          University of California, San Francisco
        Dec 22, 2022

        COPD Exacerbation Acute Trial in Rochester (CUVITRU - Ig subcutaneous human 20%, Standard Medical Therapy)

        Not yet recruiting
        • COPD Exacerbation Acute
        • CUVITRU - Ig subcutaneous human 20%
        • Standard Medical Therapy
        • Rochester, New York
        • +2 more
        Feb 28, 2023

        Metastatic Melanoma, Squamous Cell Skin Carcinoma Trial (Ad-MAGEA3, MG1-MAGEA3, Pembrolizumab)

        Withdrawn
        • Metastatic Melanoma
        • Squamous Cell Skin Carcinoma
        • (no location specified)
        Apr 1, 2021

        Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

        Recruiting
        • Diffuse Large B Cell Lymphoma
        • Itacitinib
        • Chimeric antigen receptor (CAR) T-cell therapy
        • Tampa, Florida
          Moffitt Cancer Center
        Mar 6, 2023